将FUS释放到细胞外空间受到其氨基终端类域的调节
1School of Pharmacy at Fukuoka, International University of Health and Welfare, Fukuoka, Japan.
FEBS letters
|December 31, 2024
概括
从神经元释放的化在肉瘤 (FUS) 蛋白质是肌缩侧面硬化症 (ALS) 传播的关键. 这项研究表明,人类的FUS是由神经元释放出来的,由其氨基终端区域驱动.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种神经退行性疾病.
- 融合在肉瘤 (FUS) 蛋白质聚合与ALS病变发生有关.
- 细胞对细胞的FUS传播是ALS进展的一个拟议机制.
研究的目的:
- 研究神经元中FUS释放的机制.
- 确定影响人类与小鼠FUS差异释放的因素.
- 了解FUS域在其分泌中的作用.
主要方法:
- 从培养的神经元中释放的人类和小鼠FUS的分析.
- 利用仿真FUS蛋白来绘制功能域的地图.
- 在细胞介质中的FUS蛋白质的量化.
主要成果:
- 人类FUS显著地从神经元释放到细胞外环境中.
- 与人类FUS相比,老鼠FUS的释放量明显较低.
- 人类FUS的氨基末端区域被确定为其释放的关键区域.
结论:
- 人类的FUS直接从神经元中释放出来,这是ALS研究中的新发现.
- FUS的氨基末端区域在它的分泌中起着至关重要的作用.
- 了解FUS释放机制可能为ALS提供新的治疗点.
相关概念视频
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Fusion of Secretory Vesicles with the Plasma Membrane
10.9K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
10.9K
The Unfolded Protein Response
4.4K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.4K
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Regulation of Expression at Multiple Steps
869
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
869


